Shanghai municipal science and technology commission, development and reform
commission and other departments issued measures to speed commercialization and
customs clearance of imported drugs for foreign biopharma companies.
Overseas‑market drugs that obtain Chinese approval may place pre‑approval
production batches on sale if they meet drug release requirements; authorities
will provide enhanced business guidance and services. The plan integrates import
sampling and testing and enables 24‑hour clearance facilitation to speed
circulation of clinically urgent imports. Batch‑release testing for biologics
and customs inspection for imported drugs will be accelerated: sampling must
occur within 3 working days of arrival, and per‑batch sample volume is cut from
3x to 2x of the full‑item inspection amount.
